About Mediwise
Mediwise is a Healthcare company based in London (United Kingdom) founded in 2010, and was acquired by Metamaterial in July 2018. Patient solutions using wireless sensing technology. It operates in the Healthcare and Technology sectors. The company was acqui-hired. Its focus areas include Life Sciences, Oncology, Medical Devices and Imaging.
Company details
MediWiSe designs and develops innovative wireless devices in the fields of medical diagnostics and monitoring. MediWise has patented use of radio waves for accurate non-invasive diagnostics. Its offerings: GlucoWise, a non-invasive glucose monitor and mobile platform for diabetes management. MiScan, radio-wave imaging scanner with applications in emergency medicine or early stage breast screening. RadiWise, real-time implantable radiation sensor for cancer patients undergoing radiotherapy treatments.
- Headquarters London, United Kingdom
- Stage Acquired
- SectorsHealthcareTechnology
- Website parked.mediwise.co.uk
- Social LinkedIn X
- Acquired by Metamaterial (Jul 2018)
- Investors
- Acquired byMetamaterial
(Jul 2018)
Investors in Mediwise
Mediwise has secured backing from 1 investor. Prominent investors backing the company include Metamaterial.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Metamaterials are manufactured and applied across various industries. | 2011 | metamaterial.com | Halifax, Canada |
Investor details for Mediwise
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Mediwise
2 dated milestones of Mediwise across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Mediwise is founded.
- Exit Acquired by Metamaterial.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Mediwise
Mediwise was founded in 2010.
Mediwise is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
MediWiSe designs and develops innovative wireless devices in the fields of medical diagnostics and monitoring. MediWise has patented use of radio waves for accurate non-invasive diagnostics. Its offerings: GlucoWise, a non-invasive glucose monitor and mobile platform for diabetes management. MiScan, radio-wave imaging scanner with applications in emergency medicine or early stage breast screening. RadiWise, real-time implantable radiation sensor for cancer patients undergoing radiotherapy treatments.
Mediwise has 1 investor. Key investors include Metamaterial.
Yes. Mediwise was acquired by Metamaterial in July 2018.